Surgical Ablation for Atrial Fibrillation During Minimally Invasive Mitral Valve Surgery: Risk Dependencies and Long-Term Survival
- 1 July 2026
- journal article
- research article
- Published by SAGE Publications in Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
- Vol. 21 (4) , 368-376
Abstract
Objective: Atrial fibrillation (AF) is a common finding among patients with mitral valve disease, with a growing body of evidence showing survival benefits associated with surgical ablation (SA). However, a lack of data persists regarding the safety and survival after SA concomitant to minimally invasive mitral valve surgery (MIMVS). Methods: We retrospectively collected data from the Polish National Registry of Cardiac Surgery Procedures (Krajowy Rejestr Operacji Kardiochirurgicznych), searching for all adult patients with AF who underwent MIMVS between 2006 and 2021. Initially, 1,545 patients were identified; SA was performed on 512 patients (33.2%). Propensity score matching comparing MIMVS + SA versus MIMVS alone was performed. Results: Matching resulted in 365 pairs with similar baseline characteristics (median age = 65 years, interquartile range [IQR]: 58 to 70 years; median EuroSCORE II = 2.2%, IQR: 1.4 to 3.4). We observed no differences in 24 h mortality for MIMVS + SA versus MIMVS alone (0.3% vs 0.0%, P = 0.99). Although there was no difference in in-hospital complications, neurologic complications were reported less frequently in the SA group (2.7% vs 8.2%, P = 0.002). Unadjusted survival analysis favored MIMVS+SA (hazard ratio [HR] = 0.52, 95% confidence interval [CI]: 0.40 to 0.69, P < 0.001). However, after adjustment for baseline risk factors, the effect was no longer significant (HR = 0.85, 95% CI: 0.56 to 1.32, P = 0.48). When stratified on baseline CHA 2 DS 2 -VASc score, a gradient of benefit was seen, with patients at higher thromboembolic risk gaining the most benefits from concomitant SA. Conclusions: Patients with a higher thromboembolic risk gain the most benefits from concomitant SA. SA was associated with fewer neurologic complications.Keywords
This publication has 29 references indexed in Scilit:
- The left atrial appendage exclusion for prophylactic stroke reduction (LEAAPS) trial: Rationale and designAmerican Heart Journal, 2024
- Pulmonary hypertension: An unexplored risk factor for stroke in patients with atrial fibrillationJournal of Stroke and Cerebrovascular Diseases, 2023
- Imaging for Patient’s Selection and Guidance of LAA and ASD Percutaneous and Surgical ClosureJACC: Cardiovascular Imaging, 2021
- Functional mitral regurgitation, updated: ventricular or atrial?Journal of Echocardiography, 2019
- Neural network models and deep learningCurrent Biology, 2019
- Clinical Prediction Models2019
- The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial FibrillationThe Annals of Thoracic Surgery, 2017
- Does Preoperative Atrial Fibrillation Portend a Poorer Prognosis in Patients Undergoing Isolated Aortic Valve Replacement? A Multicentre Australian StudyCanadian Journal of Cardiology, 2013
- Minimally invasive versus conventional mitral valve surgery: A propensity-matched comparisonThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial FibrillationJAMA, 2005